No Abstract BioWorld International CorrespondentPARIS - Cytheris SA has received a €1.5 million (US$2.3 million) interest-free loan from OSEO, France's national industrial innovation agency, to support its continuing clinical development program in hepatitis C (HCV).The funds will enable Paris-based Cytheris to push ahead with the development of its lead product, recombinant human Interleukin-7 (r-hIL-7), a critical growth factor for immune T-cell recovery and enhancement.

No Abstract BioWorld International CorrespondentPARIS - Ariana Pharma, which is developing decision-support tools to support the drug discovery process, closed a series A funding round in which it raised €1.5 million (US$2.35 million).